NIH Office of Technology Transfer:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NIH Office of Technology Transfer - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12381
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NIH Office of Technology Transfer (NIH OTT), a subsidiary of National Institutes of Health is a healthcare service provider that evaluates, protects, markets, licenses, monitors, and manages NIH and FDA discoveries, inventions, and other intellectual property. The center discovers new biological molecules, processes and pathways, medical technologies, and innovative applications to improve public health. It provides licensing and royalties that include licensing opportunities, royalties, startups, non-profit license, neglected diseases and rare diseases; initiating cooperative research and development agreements. NIH OTT transfers its medical knowledge from its laboratories to other organizations for the purpose of developing that knowledge into medical products. The center also offers training associated with technology transfer presentations and articles, intramural research training award fellowships, internship opportunities in federal technology transfer, and international training opportunities in federal technology transfer. NIH OTT is headquartered in Rockville, Maryland, the US.

NIH Office of Technology Transfer – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NIH Office of Technology Transfer, Medical Devices Deals, 2012 to YTD 2018 9
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
KannaLife Sciences Enters Into Licensing Agreement With NIH 11
JSK Therapeutics Enters Into Licensing Agreement with NIH Office of Technology Transfer 12
KannaLife Sciences Enters Into Licensing Agreement With NIH-OTT 13
NIH Office of Technology Transfer – Key Competitors 14
NIH Office of Technology Transfer – Key Employees 15
NIH Office of Technology Transfer – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Key Facts 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NIH Office of Technology Transfer, Deals By Therapy Area, 2012 to YTD 2018 8
NIH Office of Technology Transfer, Medical Devices Deals, 2012 to YTD 2018 9
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
KannaLife Sciences Enters Into Licensing Agreement With NIH 11
JSK Therapeutics Enters Into Licensing Agreement with NIH Office of Technology Transfer 12
KannaLife Sciences Enters Into Licensing Agreement With NIH-OTT 13
NIH Office of Technology Transfer, Key Competitors 14
NIH Office of Technology Transfer, Key Employees 15

List of Figures
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NIH Office of Technology Transfer, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[NIH Office of Technology Transfer:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Transat A.T. Inc:企業の戦略・SWOT・財務情報
    Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report Summary Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • VAALCO Energy Inc (EGY):企業の財務・戦略的SWOT分析
    VAALCO Energy Inc (EGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Mudman Public Company Limited (MM):企業の財務・戦略的SWOT分析
    Mudman Public Company Limited (MM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Medpace Holdings Inc (MEDP):企業の財務・戦略的SWOT分析
    Medpace Holdings Inc (MEDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Quanta Services Inc (PWR):企業の財務・戦略的SWOT分析
    Quanta Services Inc (PWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • G4S Plc (GFS):企業の財務・戦略的SWOT分析
    G4S Plc (GFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Diamyd Medical AB (DMYD B):企業の財務・戦略的SWOT分析
    Summary Diamyd Medical AB (Diamyd), formerly Diamyd Therapeutics AB is a drug development company that offers diabetes vaccine. The company's diabetes products include Diamyd, an antigen-based immunotherapy for the treatment of autoimmune diabetes. Its pipeline products include GAD, GABA, and other …
  • TTM Technologies, Inc.:企業の戦略・SWOT・財務情報
    TTM Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary TTM Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • FIT Biotech Oy (FITBIO):企業の財務・戦略的SWOT分析
    Summary FIT Biotech Oy (FIT Biotech), formerly Finnish Immunotechnology Oy is a biotechnology company that develops and commercializes gene-based treatments for cancer and a range of infectious diseases. Its patented gene transfer technology is used for the development of drug candidates which inclu …
  • Senetas Corporation Limited:企業の戦略・SWOT・財務分析
    Senetas Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Senetas Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Malakoff Corporation Berhad:発電所・企業SWOT分析
    Malakoff Corporation Berhad - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …
  • Ekarat Engineering (Public) Co Ltd (AKR):企業の財務・戦略的SWOT分析
    Ekarat Engineering (Public) Co Ltd (AKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Arla Foods Ingredients Group P/S:戦略・SWOT・企業財務分析
    Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report Summary Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Antibe Therapeutics Inc (ATE):製薬・医療:M&Aディール及び事業提携情報
    Summary Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen deriv …
  • The Council of Europe Development Bank:企業の戦略・SWOT・財務情報
    The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report Summary The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Geokinetics Inc:企業の戦略的SWOT分析
    Geokinetics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Circle Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Circle Pharma Inc (Circle Pharma) is a developer of cell permeable macrocyclic peptide therapies by combining structure-based computational design and synthetic chemistry. The company’s automated chemistry synthesis enable to assess, in parallel, multiple design hypotheses for given target, …
  • Industrial and Commercial Bank of China Ltd:戦略・SWOT・企業財務分析
    Industrial and Commercial Bank of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Industrial and Commercial Bank of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Savola Group Co:企業の戦略・SWOT・財務情報
    Savola Group Co - Strategy, SWOT and Corporate Finance Report Summary Savola Group Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • National Fuel Gas Co (NFG):企業の財務・戦略的SWOT分析
    National Fuel Gas Co (NFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆